Helus Pharma Inc.
For the period ended Mar 31, 2024. Filed Jun 26, 2024.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Jun 26, 2024
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Note:
Note:
(1) Source: CBOE Exchange trading data as of the date of this AIF.
As the close of business on June 25, 2024, the date of this AIF, the price of the Common Shares as quoted by the Exchange was $0.36 per Common Share.
| NYSE American Price Range | |||
|---|---|---|---|
| Month(1) | High (US$) | Low (US$) | Volume |
| April 2023 | 0.40 | 0.29 | 18,366,468 |
| May 2023 | 0.35 | 0.26 | 26,443,776 |
| June 2023 | 0.39 | 0.21 | 49,472,709 |
| July 2023 | 0.53 | 0.37 | 54,877,677 |
| August 2023 | 0.37 | 0.28 | 68,425,653 |
| September 2023 | 0.72 | 0.30 | 147,886,989 |
| October 2023 | 0.74 | 0.42 | 95,997,620 |
| November 2023 | 0.66 | 0.40 | 91,114,131 |
| December 2023 | 0.46 | 0.38 | 62,237,059 |
| January 2024 | 0.45 | 0.34 | 75,594,426 |
| February 2024 | 0.40 | 0.28 | 70,978,585 |
| March 2024 | 0.52 | 0.31 | 181,116,104 |
Notes:
(1) Source: NYSE as of the date of this AIF.
As the close of business on June 25, 2024, the date of this AIF, the price of the Common Shares as quoted by the NYSE American was US$0.264 per Common Share.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.